You have 9 free searches left this month | for more free features.

Anemia, Sickle Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,

Completed
  • Hemophagocytic Lymphohistiocytosis
  • +5 more
  • Hematopoietic Stem Cell Transplant
  • Birmingham, Alabama
  • +21 more
Dec 6, 2022

Type 2 Diabetes, Obesity, Bariatric Surgery Candidate Trial in Aurora (Aminohippurate Sodium Inj 20%, Iohexol Inj 300 mg/mL,

Recruiting
  • Type 2 Diabetes Mellitus
  • +11 more
  • Aminohippurate Sodium Inj 20%
  • +3 more
  • Aurora, Colorado
    Children's Hospital Colorado
Jan 28, 2022

Active Immune Response Trial in Klamath Falls (Herbal tea blend, Warm water)

Recruiting
  • Active Immune Response
  • Herbal tea blend
  • Warm water
  • Klamath Falls, Oregon
    Gitte Jensen
Jun 29, 2021

Lymphoma, Mantle-Cell Trial in Czechia (Polatuzumab vedotin, Bendamustine Hydrochloride, Rituximab)

Not yet recruiting
  • Lymphoma, Mantle-Cell
  • Polatuzumab vedotin
  • +2 more
  • Brno, Czechia
  • +6 more
May 28, 2021

Anemia Trial in Worldwide (Roxadustat, Epoetin alfa)

Completed
  • Anemia
  • Huntsville, Alabama
  • +188 more
Nov 27, 2019

Non-Hodgkin's B-cell Lymphoma Trial in Tianjin (CD19/CD20-directed CAR-T cells)

Recruiting
  • Non-Hodgkin's B-cell Lymphoma
  • CD19/CD20-directed CAR-T cells
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hosipital
Jan 5, 2021

Irritable Bowel Syndrome-like Symptoms, Crohn Disease Remission Trial (BK003, Placebo)

Not yet recruiting
  • Irritable Bowel Syndrome-like Symptoms
  • Crohn Disease Remission
  • BK003
  • Placebo
  • (no location specified)
Oct 23, 2023

Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)

Recruiting
  • Breast Cancer
  • 99mTc-MY6349 SPECT/CT scan
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

Enrolling by invitation
  • Monoclonal Gammopathy of Undetermined Significance
  • +6 more
    • Milwaukee, Wisconsin
      Aurora Health Care
    Jul 20, 2021

    Renal Cell Carcinoma Trial in Philadelphia (drug, genetic, other, procedure)

    Terminated
    • Renal Cell Carcinoma
    • Brivanib alaninate
    • +5 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Mar 18, 2021

    Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer Trial (BI 765049, Ezabenlimab)

    Not yet recruiting
    • Gastrointestinal Cancer
    • +5 more
    • (no location specified)
    Oct 16, 2023

    Diffuse B-Cell Lymphoma Trial in Worldwide (Avadomide (CC-122), Rituximab, Cyclophosphamide 750mg/m2 by IV infusion)

    Completed
    • Diffuse B-Cell Lymphoma
    • Avadomide (CC-122)
    • +4 more
    • Washington, District of Columbia
    • +14 more
    Apr 28, 2021

    Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)

    Active, not recruiting
    • Hodgkin Lymphoma
    • brentuximab vedotin
    • +5 more
    • Fountain Valley, California
    • +75 more
    Dec 2, 2022

    GVHD Trial run by the NHLBI (Topical Dexamethasone, Placebo)

    Completed
    • Graft vs Host Disease
    • Topical Dexamethasone
    • Placebo
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 20, 2022

    Hematopoietic Stem Cell Transplantation Trial in Seoul (Mycophenolate Mofetil)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Mycophenolate Mofetil
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Apr 29, 2021

    Incisional Hernia, Medial Hernia, Medial-lateral Hernia Trial in Samara (A new method of repair of the abdominal wall of

    Recruiting
    • Incisional Hernia
    • +2 more
    • A new method of repair of the abdominal wall of mid-lateral postoperative ventral hernias
    • Samara, Russian Federation
      Clinics of Samara State Medical University
    Feb 8, 2023

    Advanced or Metastatic Non-squamous NSCLC Trial (SHR-1701;BP102)

    Not yet recruiting
    • Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer
    • (no location specified)
    Jul 16, 2021

    Special Care Patterns for Elderly HNSCC Patients Undergoing

    Recruiting
    • HNSCC
    • +4 more
      • New York, New York
      • +11 more
      Jun 2, 2022

      Fallopian Tube Carcinoma, Recurrent Ovarian Cancer, Primary Peritoneal Carcinoma Trial in Columbus (Lenvatinib Mesylate,

      Completed
      • Fallopian Tube Carcinoma
      • +3 more
      • Lenvatinib Mesylate
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Apr 5, 2022

      Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)

      Terminated
      • Stiff-Person Syndrome
      • Autologous Hematopoietic Stem Cells
      • +6 more
      • Chicago, Illinois
        Northwestern University
      Jan 6, 2021

      Innate Lymphoid Cells in Peripheral Blood in ALS

      Terminated
      • Amyotrophic Lateral Sclerosis
      • Blood draw
      • Ann Arbor, Michigan
        University of Michigan
      Dec 22, 2021

      Extranodal NK/T-cell Lymphoma Trial in Korea, Republic of (VT-EBV-N, Placebo)

      Recruiting
      • Extranodal NK/T-cell Lymphoma
      • VT-EBV-N
      • Placebo
      • Busan, Korea, Republic of
      • +7 more
      Apr 28, 2022

      Patients With Advanced Treatment Naive LCNEC Trial in Tel Aviv (Durvalumab)

      Recruiting
      • Patients With Advanced Treatment Naive LCNEC
      • Tel Aviv, Israel
        Assuta MC
      Feb 20, 2022

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Germany (Rucaparib, Placebos)

      Recruiting
      • Ovarian Cancer
      • +3 more
      • Berlin, Germany
      • +22 more
      Aug 30, 2021

      Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

      Recruiting
      • Multiple Myeloma
      • anti-BCMA/GPRC5D CAR-T CELL
      • Xuzhou, Jiangsu, China
        Kailin Xu
      Aug 19, 2022